Novo Holdings A/S is 10% Owner at KalVista Pharmaceuticals, Inc. (KALV). They have made 64 open-market trades across 31 companies since 2017, most recently 2026-05-01.
CIK 0001388325
24 open-market purchases totalling $200.9M since 2017, against 40 sales. Across 24 scored buys the stock is down 11.7% at ninety days, and 14.1 points behind the S&P over the same stretch.
24 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 46% | 42% | 38% |
| Avg Move | +0.4% | -4.1% | -11.7% |
| Alpha | +0.4% | -4.7% | -14.1% |
| Scored | 24 | 24 | 24 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 53% | 48% | 40% |
| Avg Move | +5.2% | +10.0% | +29.3% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AVLN | BUY | 2026-05-01 | 2026-05-05 | $18.00 | $10.0M | +12.0% | +1.5% | +6.5% |
| MPLT | BUY | 2025-10-28 | 2025-10-30 | $17.00 | $16.2M | -19.3% | -27.2% | +1.0% |
| IOBT | SELL | 2024-07-25 | 2024-07-26 | $1.33 | $168K | -0.8% | +18.0% | -8.3% |
| IOBT | SELL | 2024-05-10 | 2024-05-14 | $1.22 | $1.6M | -14.8% | -14.1% | -12.8% |
| SPRB | SELL | 2024-03-21 | 2024-03-25 | $0.75 | $698K | +17.0% | -2.3% | -24.8% |
| SPRB | SELL | 2024-03-18 | 2024-03-20 | $0.76 | $2.3M | +14.7% | -5.4% | -14.8% |
| SPRB | SELL | 2024-03-14 | 2024-03-18 | $0.89 | $3.4M | +5.9% | -4.8% | -12.0% |
| MGX | BUY | 2024-02-09 | 2024-02-15 | $14.47 | $13.0M | -5.2% | -8.9% | -44.0% |
| IOBT | SELL | 2024-02-09 | 2024-02-13 | $1.50 | $2.0M | -4.9% | +4.3% | -13.5% |
| IOBT | BUY | 2023-08-09 | 2023-08-11 | $2.03 | $10.0M | +4.1% | -13.9% | -51.5% |
| CYT | SELL | 2023-07-19 | 2023-07-20 | $2.75 | $280K | -0.7% | -0.7% | +9.5% |
| CYT | SELL | 2023-07-14 | 2023-07-18 | $2.75 | $106K | -1.4% | -1.8% | +9.0% |
| CYT | SELL | 2023-06-30 | 2023-07-03 | $2.63 | $1.1M | +0.4% | +0.0% | +4.0% |
| IRON | SELL | 2023-06-28 | 2023-06-28 | $46.10 | $57.6M | -0.4% | +0.9% | +0.9% |
| CYT | SELL | 2023-06-26 | 2023-06-28 | $1.77 | $128K | +56.8% | +55.7% | +58.5% |
| RPHM | SELL | 2023-06-23 | 2023-06-23 | $7.10 | $710K | -3.6% | -10.7% | +0.7% |
| CYT | SELL | 2023-06-21 | 2023-06-23 | $1.94 | $26K | +48.6% | +49.2% | +51.4% |
| CYT | SELL | 2023-06-15 | 2023-06-20 | $2.03 | $34K | +27.5% | +34.8% | +36.8% |
| CYT | SELL | 2023-06-12 | 2023-06-14 | $2.10 | $13K | -16.0% | +29.2% | +30.7% |
| SPRB | BUY | 2023-02-16 | 2023-02-21 | $3.17 | $7.0M | -6.3% | -10.5% | -3.9% |
| EWTX | BUY | 2022-09-14 | 2022-09-16 | $10.32 | $10.0M | +9.1% | +0.8% | -20.8% |
| CYT | SELL | 2022-07-20 | 2022-07-22 | $3.00 | $2.7M | -35.8% | -37.7% | -51.4% |
| BOLT | SELL | 2022-07-13 | 2022-07-15 | $2.00 | $1.6M | -5.5% | -12.6% | -43.5% |
| CMPI | SELL | 2022-02-23 | 2022-02-25 | $2.84 | $23K | +22.7% | +16.9% | +277.0% |
| ACLX | BUY | 2022-02-08 | 2022-02-09 | $15.00 | $12.5M | +9.8% | -1.8% | -43.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| SPRB | 2,550,000 | $101.3M |
| AVLN | 3,883,289 | $92.2M |
| ANAB | 1,936,604 | $90.2M |
| IRON | 1,090,772 | $62.1M |
| GLTO | 2,164,458 | $62.1M |
| KALV | 1,955,747 | $52.8M |
| CMPI | 2,168,280 | $22.8M |
| MPLT | 2,733,681 | $21.0M |
| CRVS | 2,130,938 | $20.3M |
| BOLT | 3,703,991 | $15.9M |
| APEN | 1,310,268 | $13.1M |
| INGN | 2,079,320 | $13.0M |
| ALGS | 2,414,563 | $12.0M |
| CYT | 3,622,136 | $10.9M |
| INZY | 2,194,379 | $8.8M |
| RPHM | 3,330,337 | $6.1M |
| VERV | 443,265 | $4.9M |
| NKTX | 2,238,310 | $4.1M |
| ETTX | 1,092,008 | $2.4M |
| UTRS | 1,477,132 | $2.2M |
| EAR | 737,071 | $1.9M |
| MIST | 2,434,470 | $1.7M |
| MGX | 939,175 | $749K |
| HTGM | 1,102,651 | $529K |
| GRTX | 2,459,021 | $357K |
| IOBT | 4,354,449 | $218K |
| Total | $2.4B |
Shares reported on the most recent Form 4, priced at the 2026-05-05 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 40 | 40 | 40 |